Loading…

Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables

We investigated cyclin D1 expression in proliferative endometrium, endometrial hyperplasia and endometrioid adenocarcinoma, and examined the correlation of cyclin D1 expression with Ki67 as a cell proliferation associated marker. Immunohistochemical expression of cyclin D1 and Ki67 were studied in 3...

Full description

Saved in:
Bibliographic Details
Published in:Archives of gynecology and obstetrics 2005-02, Vol.271 (2), p.123-126
Main Authors: Ozuysal, Sema, Oztürk, Hülya, Bilgin, Tufan, Filiz, Gülaydan
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c242t-8ab065153f72bf9915906102eb821e366fef03eb0ce9e576716b44939640795b3
cites cdi_FETCH-LOGICAL-c242t-8ab065153f72bf9915906102eb821e366fef03eb0ce9e576716b44939640795b3
container_end_page 126
container_issue 2
container_start_page 123
container_title Archives of gynecology and obstetrics
container_volume 271
creator Ozuysal, Sema
Oztürk, Hülya
Bilgin, Tufan
Filiz, Gülaydan
description We investigated cyclin D1 expression in proliferative endometrium, endometrial hyperplasia and endometrioid adenocarcinoma, and examined the correlation of cyclin D1 expression with Ki67 as a cell proliferation associated marker. Immunohistochemical expression of cyclin D1 and Ki67 were studied in 30 cases with endometrial carcinoma, 14 cases with atypical hyperplasia, 15 cases with simple hyperplasia and 30 cases with proliferative endometrium. One out of 30 patients (3.3%) with proliferative endometrium, 1 out of 14 patients (7.1%) with atypical hyperplasia, and 8 out of 30 patients (26.6%) with endometrial carcinoma were found to have immunoreactivity to cyclin D1. All cases of simple hyperplasia had negative staining for cyclin D1. A positive immunoreaction for Ki67 was obtained in all cases. Statistically significant difference was found in cyclin D1 immunoreactivity between both proliferative endometrium and adenocarcinoma, and simple hyperplasia and adenocarcinoma (p
doi_str_mv 10.1007/s00404-003-0595-5
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2261883580</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2261883580</sourcerecordid><originalsourceid>FETCH-LOGICAL-c242t-8ab065153f72bf9915906102eb821e366fef03eb0ce9e576716b44939640795b3</originalsourceid><addsrcrecordid>eNpFkMtu1DAUhi0EotPCA7BBltg27fE9XqLSC2qlbtq15XhOGFdJHOxMYZ6Bl27SGdTNuej_z3-kj5AvDM4YgDkvABJkBSAqUFZV6h1ZMSl4BYax92QFdplBmyNyXMoTAON1rT-SIyaNBC5gRf5d_h0zlhLTQFNLwy50caA_GJ3rkHLvu1O62Y2Yx86XKQbqhzUdMP1fcVinHqcct_2rFKdCQ8oZOz8tmX_itKG3sdLmVV7SY0ijnzapS79i8B199jn6psPyiXxofVfw86GfkMery4eLm-ru_vrnxfe7KnDJp6r2DWjFlGgNb1prmbKgGXBsas5QaN1iCwIbCGhRGW2YbqS0wmoJxqpGnJBv-9wxp99bLJN7Sts8zC8d55rVtVA1zC62d4WcSsnYujHH3uedY-AW_G6P38343YLfqfnm6yF52_S4frs48BYvGjGA4Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2261883580</pqid></control><display><type>article</type><title>Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables</title><source>Springer Nature</source><creator>Ozuysal, Sema ; Oztürk, Hülya ; Bilgin, Tufan ; Filiz, Gülaydan</creator><creatorcontrib>Ozuysal, Sema ; Oztürk, Hülya ; Bilgin, Tufan ; Filiz, Gülaydan</creatorcontrib><description>We investigated cyclin D1 expression in proliferative endometrium, endometrial hyperplasia and endometrioid adenocarcinoma, and examined the correlation of cyclin D1 expression with Ki67 as a cell proliferation associated marker. Immunohistochemical expression of cyclin D1 and Ki67 were studied in 30 cases with endometrial carcinoma, 14 cases with atypical hyperplasia, 15 cases with simple hyperplasia and 30 cases with proliferative endometrium. One out of 30 patients (3.3%) with proliferative endometrium, 1 out of 14 patients (7.1%) with atypical hyperplasia, and 8 out of 30 patients (26.6%) with endometrial carcinoma were found to have immunoreactivity to cyclin D1. All cases of simple hyperplasia had negative staining for cyclin D1. A positive immunoreaction for Ki67 was obtained in all cases. Statistically significant difference was found in cyclin D1 immunoreactivity between both proliferative endometrium and adenocarcinoma, and simple hyperplasia and adenocarcinoma (p&lt;0.05). In patients with adenocarcinoma, cyclin D1 immunoreactive cases had higher mean Ki67 values compared with the non-immunoreactive ones (p&lt;0.05). Ki67 and cyclin D1 immunoreactivity had no impact on overall survival. Univariate analysis revealed a significant relationship between survival and grade and stage (p&lt;0.01). Cyclin D1 expression was not correlated with age, depth of myometrial invasion, lymphovascular space involvement, grade, lymph node metastasis and stage. Cyclin D1 expression in endometrial carcinoma is higher than proliferative endometrium and simple hyperplasia. These findings support that cyclin D1 may play a role in endometrial carcinogenesis.</description><identifier>ISSN: 0932-0067</identifier><identifier>EISSN: 1432-0711</identifier><identifier>DOI: 10.1007/s00404-003-0595-5</identifier><identifier>PMID: 14740230</identifier><language>eng</language><publisher>Germany: Springer Nature B.V</publisher><subject>Biomarkers ; Carcinoma, Endometrioid - metabolism ; Cell Proliferation ; Cyclin D1 - biosynthesis ; Endometrial cancer ; Endometrial Hyperplasia - metabolism ; Endometrial Neoplasms - metabolism ; Endometrium - metabolism ; Female ; Humans ; Ki-67 Antigen - analysis ; Middle Aged</subject><ispartof>Archives of gynecology and obstetrics, 2005-02, Vol.271 (2), p.123-126</ispartof><rights>Archives of Gynecology and Obstetrics is a copyright of Springer, (2004). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c242t-8ab065153f72bf9915906102eb821e366fef03eb0ce9e576716b44939640795b3</citedby><cites>FETCH-LOGICAL-c242t-8ab065153f72bf9915906102eb821e366fef03eb0ce9e576716b44939640795b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14740230$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ozuysal, Sema</creatorcontrib><creatorcontrib>Oztürk, Hülya</creatorcontrib><creatorcontrib>Bilgin, Tufan</creatorcontrib><creatorcontrib>Filiz, Gülaydan</creatorcontrib><title>Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables</title><title>Archives of gynecology and obstetrics</title><addtitle>Arch Gynecol Obstet</addtitle><description>We investigated cyclin D1 expression in proliferative endometrium, endometrial hyperplasia and endometrioid adenocarcinoma, and examined the correlation of cyclin D1 expression with Ki67 as a cell proliferation associated marker. Immunohistochemical expression of cyclin D1 and Ki67 were studied in 30 cases with endometrial carcinoma, 14 cases with atypical hyperplasia, 15 cases with simple hyperplasia and 30 cases with proliferative endometrium. One out of 30 patients (3.3%) with proliferative endometrium, 1 out of 14 patients (7.1%) with atypical hyperplasia, and 8 out of 30 patients (26.6%) with endometrial carcinoma were found to have immunoreactivity to cyclin D1. All cases of simple hyperplasia had negative staining for cyclin D1. A positive immunoreaction for Ki67 was obtained in all cases. Statistically significant difference was found in cyclin D1 immunoreactivity between both proliferative endometrium and adenocarcinoma, and simple hyperplasia and adenocarcinoma (p&lt;0.05). In patients with adenocarcinoma, cyclin D1 immunoreactive cases had higher mean Ki67 values compared with the non-immunoreactive ones (p&lt;0.05). Ki67 and cyclin D1 immunoreactivity had no impact on overall survival. Univariate analysis revealed a significant relationship between survival and grade and stage (p&lt;0.01). Cyclin D1 expression was not correlated with age, depth of myometrial invasion, lymphovascular space involvement, grade, lymph node metastasis and stage. Cyclin D1 expression in endometrial carcinoma is higher than proliferative endometrium and simple hyperplasia. These findings support that cyclin D1 may play a role in endometrial carcinogenesis.</description><subject>Biomarkers</subject><subject>Carcinoma, Endometrioid - metabolism</subject><subject>Cell Proliferation</subject><subject>Cyclin D1 - biosynthesis</subject><subject>Endometrial cancer</subject><subject>Endometrial Hyperplasia - metabolism</subject><subject>Endometrial Neoplasms - metabolism</subject><subject>Endometrium - metabolism</subject><subject>Female</subject><subject>Humans</subject><subject>Ki-67 Antigen - analysis</subject><subject>Middle Aged</subject><issn>0932-0067</issn><issn>1432-0711</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNpFkMtu1DAUhi0EotPCA7BBltg27fE9XqLSC2qlbtq15XhOGFdJHOxMYZ6Bl27SGdTNuej_z3-kj5AvDM4YgDkvABJkBSAqUFZV6h1ZMSl4BYax92QFdplBmyNyXMoTAON1rT-SIyaNBC5gRf5d_h0zlhLTQFNLwy50caA_GJ3rkHLvu1O62Y2Yx86XKQbqhzUdMP1fcVinHqcct_2rFKdCQ8oZOz8tmX_itKG3sdLmVV7SY0ijnzapS79i8B199jn6psPyiXxofVfw86GfkMery4eLm-ru_vrnxfe7KnDJp6r2DWjFlGgNb1prmbKgGXBsas5QaN1iCwIbCGhRGW2YbqS0wmoJxqpGnJBv-9wxp99bLJN7Sts8zC8d55rVtVA1zC62d4WcSsnYujHH3uedY-AW_G6P38343YLfqfnm6yF52_S4frs48BYvGjGA4Q</recordid><startdate>200502</startdate><enddate>200502</enddate><creator>Ozuysal, Sema</creator><creator>Oztürk, Hülya</creator><creator>Bilgin, Tufan</creator><creator>Filiz, Gülaydan</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>200502</creationdate><title>Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables</title><author>Ozuysal, Sema ; Oztürk, Hülya ; Bilgin, Tufan ; Filiz, Gülaydan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c242t-8ab065153f72bf9915906102eb821e366fef03eb0ce9e576716b44939640795b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Biomarkers</topic><topic>Carcinoma, Endometrioid - metabolism</topic><topic>Cell Proliferation</topic><topic>Cyclin D1 - biosynthesis</topic><topic>Endometrial cancer</topic><topic>Endometrial Hyperplasia - metabolism</topic><topic>Endometrial Neoplasms - metabolism</topic><topic>Endometrium - metabolism</topic><topic>Female</topic><topic>Humans</topic><topic>Ki-67 Antigen - analysis</topic><topic>Middle Aged</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ozuysal, Sema</creatorcontrib><creatorcontrib>Oztürk, Hülya</creatorcontrib><creatorcontrib>Bilgin, Tufan</creatorcontrib><creatorcontrib>Filiz, Gülaydan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Archives of gynecology and obstetrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ozuysal, Sema</au><au>Oztürk, Hülya</au><au>Bilgin, Tufan</au><au>Filiz, Gülaydan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables</atitle><jtitle>Archives of gynecology and obstetrics</jtitle><addtitle>Arch Gynecol Obstet</addtitle><date>2005-02</date><risdate>2005</risdate><volume>271</volume><issue>2</issue><spage>123</spage><epage>126</epage><pages>123-126</pages><issn>0932-0067</issn><eissn>1432-0711</eissn><abstract>We investigated cyclin D1 expression in proliferative endometrium, endometrial hyperplasia and endometrioid adenocarcinoma, and examined the correlation of cyclin D1 expression with Ki67 as a cell proliferation associated marker. Immunohistochemical expression of cyclin D1 and Ki67 were studied in 30 cases with endometrial carcinoma, 14 cases with atypical hyperplasia, 15 cases with simple hyperplasia and 30 cases with proliferative endometrium. One out of 30 patients (3.3%) with proliferative endometrium, 1 out of 14 patients (7.1%) with atypical hyperplasia, and 8 out of 30 patients (26.6%) with endometrial carcinoma were found to have immunoreactivity to cyclin D1. All cases of simple hyperplasia had negative staining for cyclin D1. A positive immunoreaction for Ki67 was obtained in all cases. Statistically significant difference was found in cyclin D1 immunoreactivity between both proliferative endometrium and adenocarcinoma, and simple hyperplasia and adenocarcinoma (p&lt;0.05). In patients with adenocarcinoma, cyclin D1 immunoreactive cases had higher mean Ki67 values compared with the non-immunoreactive ones (p&lt;0.05). Ki67 and cyclin D1 immunoreactivity had no impact on overall survival. Univariate analysis revealed a significant relationship between survival and grade and stage (p&lt;0.01). Cyclin D1 expression was not correlated with age, depth of myometrial invasion, lymphovascular space involvement, grade, lymph node metastasis and stage. Cyclin D1 expression in endometrial carcinoma is higher than proliferative endometrium and simple hyperplasia. These findings support that cyclin D1 may play a role in endometrial carcinogenesis.</abstract><cop>Germany</cop><pub>Springer Nature B.V</pub><pmid>14740230</pmid><doi>10.1007/s00404-003-0595-5</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0932-0067
ispartof Archives of gynecology and obstetrics, 2005-02, Vol.271 (2), p.123-126
issn 0932-0067
1432-0711
language eng
recordid cdi_proquest_journals_2261883580
source Springer Nature
subjects Biomarkers
Carcinoma, Endometrioid - metabolism
Cell Proliferation
Cyclin D1 - biosynthesis
Endometrial cancer
Endometrial Hyperplasia - metabolism
Endometrial Neoplasms - metabolism
Endometrium - metabolism
Female
Humans
Ki-67 Antigen - analysis
Middle Aged
title Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T12%3A46%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expression%20of%20cyclin%20D1%20in%20normal,%20hyperplastic%20and%20neoplastic%20endometrium%20and%20its%20correlation%20with%20Ki-67%20and%20clinicopathological%20variables&rft.jtitle=Archives%20of%20gynecology%20and%20obstetrics&rft.au=Ozuysal,%20Sema&rft.date=2005-02&rft.volume=271&rft.issue=2&rft.spage=123&rft.epage=126&rft.pages=123-126&rft.issn=0932-0067&rft.eissn=1432-0711&rft_id=info:doi/10.1007/s00404-003-0595-5&rft_dat=%3Cproquest_cross%3E2261883580%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c242t-8ab065153f72bf9915906102eb821e366fef03eb0ce9e576716b44939640795b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2261883580&rft_id=info:pmid/14740230&rfr_iscdi=true